STGD1 clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • Tinlarebant in Subjects With Stargardt Disease

    open to eligible people ages 12-20

    The goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of tinlarebant in subjects with Stargardt Disease

    San Francisco 5391959, California 5332921 and other locations

Last updated: